These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11428679)
1. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles. Yeh MK; Tung SM; Lu DW; Chen JL; Chiang CH J Microencapsul; 2001; 18(4):507-19. PubMed ID: 11428679 [TBL] [Abstract][Full Text] [Related]
2. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Yeh MK J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421 [TBL] [Abstract][Full Text] [Related]
4. Wound modulation after trabeculectomy by different formulations of antimetabolites in rabbits. Lu DW; Chang CJ; Chiang CH; Yeh MK; Chou PI J Ocul Pharmacol Ther; 2000 Dec; 16(6):529-38. PubMed ID: 11132900 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide). Wang G; Tucker IG; Roberts MS; Hirst LW Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045 [TBL] [Abstract][Full Text] [Related]
6. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. Yeh MK; Liu YT; Chen JL; Chiang CH J Control Release; 2002 Aug; 82(2-3):237-47. PubMed ID: 12175740 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of an ocular delivery system of 5-fluorouracil microspheres. Chiang CH; Tung SM; Lu DW; Yeh MK J Ocul Pharmacol Ther; 2001 Dec; 17(6):545-53. PubMed ID: 11777178 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. Boisdron-Celle M; Menei P; Benoit JP J Pharm Pharmacol; 1995 Feb; 47(2):108-14. PubMed ID: 7602463 [TBL] [Abstract][Full Text] [Related]
10. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies. Li X; Xu Y; Chen G; Wei P; Ping Q Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762 [TBL] [Abstract][Full Text] [Related]
11. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer. Hussain M; Beale G; Hughes M; Akhtar S Int J Pharm; 2002 Mar; 234(1-2):129-38. PubMed ID: 11839444 [TBL] [Abstract][Full Text] [Related]
12. Inactive Vibrio cholerae whole-cell vaccine-loaded biodegradable microparticles: in vitro release and oral vaccination. Yeh M; Chiang C J Microencapsul; 2004 Feb; 21(1):91-106. PubMed ID: 14718189 [TBL] [Abstract][Full Text] [Related]
13. Depot drug delivery system for 5-fluorouracil after filtration surgery in the rabbit. Trope GE; Cheng YL; Sheardown H; Liu GS; Menon IA; Heathcote JG; Rootman DS; Chiu WJ; Gould L Can J Ophthalmol; 1994 Dec; 29(6):263-7. PubMed ID: 7834564 [TBL] [Abstract][Full Text] [Related]
14. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers. Yeh MK; Davis SS; Coombes AG Pharm Res; 1996 Nov; 13(11):1693-8. PubMed ID: 8956336 [TBL] [Abstract][Full Text] [Related]
15. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Lavelle EC; Yeh MK; Coombes AG; Davis SS Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157 [TBL] [Abstract][Full Text] [Related]
16. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets. Leelakanok N; Geary SM; Salem AK J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952 [TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. Chandy T; Das GS; Rao GH J Microencapsul; 2000; 17(5):625-38. PubMed ID: 11038121 [TBL] [Abstract][Full Text] [Related]
18. Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS). Ghaderi R; Artursson P; Carlfors J Pharm Res; 1999 May; 16(5):676-81. PubMed ID: 10350010 [TBL] [Abstract][Full Text] [Related]
19. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. Coombes AG; Yeh MK; Lavelle EC; Davis SS J Control Release; 1998 Mar; 52(3):311-20. PubMed ID: 9743451 [TBL] [Abstract][Full Text] [Related]
20. Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery. Cui LJ; Sun NX; Li XH; Huang J; Yang JG Acta Pharmacol Sin; 2008 Sep; 29(9):1021-8. PubMed ID: 18718170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]